Anti-RhD immunoglobulin in the treatment of immune thrombocytopenia

Por Cheung, Eric, Liebman, Howard A
Publicado em 2009

Treating venous thromboembolism in patients with cancer

Por Piatek, Caroline, O’Connell, Casey L, Liebman, Howard A
Publicado no Expert Rev Hematol (2012)

The ITP syndrome: pathogenic and clinical diversity

Por Cines, Douglas B., Bussel, James B., Liebman, Howard A., Luning Prak, Eline T.
Publicado em 2009

Incidental Venous Thromboembolism in Oncology Patients

Por Khorana, Alok A., O’Connell, Casey, Agnelli, Giancarlo, Liebman, Howard A., Lee, Agnes Y.Y.
Publicado em 2012

Increased Microparticle Tissue Factor Activity in Cancer Patients with Venous Thromboembolism

Por Manly, David A, Wang, Jianguo, Glover, Sam L, Kasthuri, Raj, Liebman, Howard A., Key, Nigel S, Mackman, Nigel
Publicado em 2009

Tumor-Derived Tissue Factor-Bearing Microparticles are Associated with Venous Thromboembolic Events in Malignancy

Por Zwicker, Jeffrey I., Liebman, Howard A., Neuberg, Donna, Lacroix, Romaric, Bauer, Kenneth A., Furie, Barbara C., Furie, Bruce
Publicado em 2009

Comparison of two dosing schedules for subcutaneous injections of low-dose anti-CD20 veltuzumab in relapsed immune thrombocytopenia

Por Liebman, Howard A., Saleh, Mansoor N., Bussel, James B., Negrea, O. George, Horne, Heather, Wegener, William A., Goldenberg, David M.
Publicado no Haematologica (2016)

Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update 2014

Por Lyman, Gary H., Bohlke, Kari, Khorana, Alok A., Kuderer, Nicole M., Lee, Agnes Y., Arcelus, Juan Ignacio, Balaban, Edward P., Clarke, Jeffrey M., Flowers, Christopher R., Francis, Charles W., Gates, Leigh E., Kakkar, Ajay K., Key, Nigel S., Levine, Mark N., Liebman, Howard A., Tempero, Margaret A., Wong, Sandra L., Somerfield, Mark R., Falanga, Anna
Publicado no J Clin Oncol (2015)